In triple-negative breast carcinomas (TNBCs), IGF2BP3 is also associated with tumor aggression and poor outcome by participating in the EGFR-mediated migration process (22) and promotes chemoresistance by stabilizing the mRNA of ABCG2 protein (23). This evidence concerns the gene IGF2BP3 and neoplasm.